Africa Cancer Leaders Institute

非洲癌症领袖研究所

• 批准号: 9567967
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-20 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9567967
• 关键词: Address; Advocacy; Africa; African; Area; Award; Cancer Research Project; Career Mobility; Clinical; Clinical Research; Collaborations; Country; Development; Development Plans; Electronic Medical Records and Genomics Network; Epidemic; Evaluation; Faculty; Fostering; Funding; Generations; Goals; Grant; Income; Individual; Institutes; Knowledge; Leadership; Learning; Location; Malignant Neoplasms; Mentors; Mentorship; Minority; Participant; Publications; Publishing; Records; Research; Research Personnel; Rwanda; Scholarship; Series; Training; Travel; Woman; anticancer research; cancer care; cancer therapy; career; career development; clinical development; cohort; design; education research; experience; improved; innovation; leadership development; lectures; meetings; member; outreach; patient oriented; peer; programs; public-private partnership; research and development; symposium

SUMMARY The proposed African Cancer Leaders Institute (ACLI) is a “meeting within a meeting” designed to coincide with the biennial AORTIC conference, beginning with the forthcoming, “Cancer in Africa: Making Strides, Creating Solutions” in Kigali, Rwanda, November 7-10, 2017. The ACLI will identify young clinical research leaders who are capable of leading interdisciplinary teams to improve cancer treatment in Africa. The long-term goal of the ACLI is to provide an intellectually stimulating platform to propel emerging global cancer leaders from Africa and the US to receive support for innovative cancer research in Africa, and to stimulate an African network for emerging leaders in cancer research in Africa. The ACLI platform will have annual goals and objectives set by the Education and Research Sub-Committees of AORTIC in collaboration with the ACLI program Organizers. The ACLI will widely solicit competitive applications from the US and Africa. Five emerging Leaders will be fully-funded for travel and participation in ACLI and the AORTIC conference. Five emerging Leaders from high-income countries with meritorious abstracts and application will be selected for Merit travel award in order to forge professional relationships and foster peer mentorship. Participants will attend lectures on best practices in developing a research career, identifying and developing cancer research projects, and disseminating research to a variety of audiences. Special sessions will be arranged for ACLI participants to discuss and evaluate the concepts presented at the AORTIC conference to enhance participants' learning and career development experience. All participants will have a chance to be mentored by Senior Leaders attending the main conference. Each ACLI participant will be asked to prepare a brief 15 minute overview of career accomplishments and plans for their career development activities as an emerging leader for cancer research in Africa. We will track a number of metrics including conference evaluations, career landmarks, publication records and the number of ACLI members who compete successfully for Africa focused K43 and K07 or K23 grants.

概括 拟议的非洲癌症领袖研究所（ACLI）是旨在重合的“会议中的会议” 从即将举行的“非洲癌症：大步向前的癌症开始， 2017年11月7日至10日在卢旺达基加利创建解决方案”。ACLI将确定年轻的临床研究 能够领导跨学科团队改善非洲癌症治疗的领导者。长期 ACLI的目标是提供一个智力刺激的平台，以推动新兴的全球癌症领导者 从非洲和美国获得非洲创新癌症研究的支持，并刺激非洲 非洲癌症研究的新兴领导者网络。 ACLI平台将有年度目标，并且 主动脉与ACLI合作的教育和研究小组委员会设定的目标 计划组织者。 ACLI将广泛征求美国和非洲的竞争应用。五 新兴领导者将获得全资金，参加ACLI和主动脉会议的旅行和参与。 来自高收入国家的五个新兴领导人将有杰出的摘要和应用 为了建立专业关系和促进同伴心态而被选为优异旅行奖。 参与者将参加开发研究职业，识别和发展的最佳实践讲座 癌症研究项目，并将研究传播给各种受众。特别会议将是 安排ACLI参与者讨论和评估主动脉会议上提出的概念 增强参与者的学习和职业发展经验。所有参与者都有机会 由参加主要会议的高级领导人指导。每个ACLI参与者将被要求准备 简短的15分钟概述了职业成就和他们的职业发展活动的计划 非洲癌症研究的新兴领导者。我们将跟踪许多指标，包括会议 评估，职业地标，出版记录和竞争的ACLI成员人数 成功地用于非洲专注的K43和K07或K23赠款。